0001209191-19-046516.txt : 20190819
0001209191-19-046516.hdr.sgml : 20190819
20190819160807
ACCESSION NUMBER: 0001209191-19-046516
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190815
FILED AS OF DATE: 20190819
DATE AS OF CHANGE: 20190819
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young Richard A
CENTRAL INDEX KEY: 0001490283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37813
FILM NUMBER: 191036535
MAIL ADDRESS:
STREET 1: C/O SYROS PHARMACEUTICALS, INC.
STREET 2: 620 MEMORIAL DRIVE SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001556263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453772460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 620 MEMORIAL DRIVE
STREET 2: SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-744-1340
MAIL ADDRESS:
STREET 1: 620 MEMORIAL DRIVE
STREET 2: SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: LS22, Inc.
DATE OF NAME CHANGE: 20120815
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-15
0
0001556263
Syros Pharmaceuticals, Inc.
SYRS
0001490283
Young Richard A
C/O SYROS PHARMACEUTICALS, INC.
620 MEMORIAL DRIVE, SUITE 300
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2019-08-15
4
S
0
2300
10.00
D
417801
D
Common Stock
2019-08-16
4
S
0
22700
10.00
D
395101
D
The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
/s/ Gerald E. Quirk, as attorney-in-fact
2019-08-19